Bioculture System by Figliozzi, Gianine et al.
Bioculture System  
Advancing cell, tissue, and microbiology spaceflight research aboard the 
International Space Station 
 
The Bioculture System is a cell biology 
research platform for the International 
Space Station that supports short- and 
long-duration studies involving the 
culture of living cells, microbes, and 
tissues in the unique microgravity 
environment of spaceflight.  
 
Microgravity affects most organ systems 
of the body. Research conducted in 
space is essential for us to understand 
the biological consequences of these 
effects and to develop 
countermeasures—procedures, drugs or 
devices—to protect health. Gaining a 
deeper understanding of the 
mechanistic role of gravity in the 
regulation of biological systems is a high 
priority research goal for NASA. The 
Bioculture System supports this goal by 
broadening the scope of microgravity 
experiments available to scientists. 
 
 
 Bioculture System with ten Cassettes and gas 
supply assembly shown (Image credit: Tissue 
Genesis, Inc.) 
 
 
Based upon the prior generation Cell 
Culture Module that flew on 21 space 
shuttle missions, the new system 
houses ten independent Cassettes, 
each of which may run for months 
aboard the station—far longer than the 
previous shuttle mission limit of two 
weeks. 
 
 
Human cardiomyocytes cultured onto Global 
Eukaryotic Microcarrier beads. Similar cultures 
will be flown in the validation mission (Image 
Credit: NASA, Natalya Dvorochkin) 
 
Academic and commercial researchers 
may use the Bioculture System to study 
a wide range of biological processes in 
microgravity that are relevant to human 
health. These experiments can help us 
understand how gravity affects the 
physiology, biochemistry, genetics and 
gene expression of living cells, tissues 
and microbes. For example, cells and 
tissues cultured during spaceflight may 
be characterized using various “omics” 
techniques, used for drug discovery and 
countermeasure analyses, or used to 
study infectious disease processes. 
Other possible applications, which are 
not limited to these examples, include 
spaceflight studies of tissue engineering, 
regeneration, and wound healing. 
 
Each Cassette contains a fluidics flow 
path and biochamber for perfusion-
based culturing and is divided into two 
independent temperature zones; an 
incubation zone for the biochamber, and 
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an insulated cold zone for culture 
medium or other temperature-sensitive 
solutions and collected specimens. 
Temperature control is independent for 
each cassette and the gas supply is 
shared. A power and command module 
supplies power and data ports to each 
Cassette.  
 
 
 Exploded view of an incubator Cassette. (Image 
credit: Tissue Genesis, Inc.) 
 
Automated functions include 1) user-
selected set point pre-programming of 
temperature settings, fluid flow rate, fluid 
circulation duration, fluid delivery 
modes, samplings volume and timeline, 
and injections volume and timeline and 
2) gas supply delivery.  
 
The system supports real-time 
experiment environment monitoring, 
hardware commanding, and manual 
crew operations—including change out 
of biochambers and fluid bags, 
sampling, and injections. Cultures may 
be initiated aboard the station from 
frozen or liquid stocks. Subculture is 
supported. 
 
The system provides containment for 
biospecimens up to Biological Safety 
Level 2, and chemicals up to 
toxicological hazard level 2. The 
Cassettes will fit into the ISS 
Microgravity Sciences Glovebox for 
manual operations that require 
continuous containment or a sterile field. 
The first Bioculture System will fly to the 
station aboard the SpX-5 mission in 
2014.  Station crew will install it in the 
U.S. Destiny module.  Once installed, 
the system will be monitored and 
commanded by ground staff at NASA’s 
Ames Research Center, Moffett Field, 
Calif.  
 
The goals for the first flight are to 
validate system performance and 
demonstrate manual crew operations. 
The study will involve the culture of 
cardiomyocytes and adipose tissue-
derived stem cells for a period of up to 
30 days. The system will be available for 
use by researchers after the validation 
study is completed, starting with the 
SpX-7 mission in 2015. 
 
The Bioculture System is being 
developed at Ames	  under the leadership 
of the Ames Research Center 
International Space Station Utilization 
Office and within the Space Biosciences 
Division. Tissue Genesis Inc., Honolulu, 
Hawaii, is performing the hardware 
development. Lockheed Martin is 
providing science, engineering, and 
mission operations support.  
 
This project is funded by the 
International Space Station Program at 
NASA’s Johnson Space Center, 
Houston, and the Space Life and 
Physical Sciences Research and 
Applications Division within the Human 
Exploration and Operations Mission 
Directorate at NASA Headquarters. 
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